Challenging the status flow: how artificial intelligence is advancing diagnosis of myelodysplastic neoplasms.
作者信息
Duetz Carolien, Westers Theresia M, Van de Loosdrecht Arjan A
机构信息
Department of Hematology, Amsterdam UMC Amsterdam, location VUmc, The Netherlands; Cancer Center Amsterdam.
出版信息
Haematologica. 2023 Sep 1;108(9):2271-2272. doi: 10.3324/haematol.2023.282998.
Abstract
摘要
相似文献
1
Challenging the status flow: how artificial intelligence is advancing diagnosis of myelodysplastic neoplasms.
Haematologica. 2023 Sep 1;108(9):2271-2272. doi: 10.3324/haematol.2023.282998.
2
Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry.
Haematologica. 2023 Sep 1;108(9):2435-2443. doi: 10.3324/haematol.2022.282370.
3
Human and artificial intelligence to illuminate MDS.
Blood. 2020 Nov 12;136(20):2243-2244. doi: 10.1182/blood.2020008742.
4
The role of flow cytometry in the classification of myeloid disorders.
Pathologie (Heidelb). 2023 Dec;44(Suppl 3):164-175. doi: 10.1007/s00292-023-01272-8. Epub 2023 Nov 22.
5
Clinical Implication of Multi-Parameter Flow Cytometry in Myelodysplastic Syndromes.
Pathobiology. 2019;86(1):14-23. doi: 10.1159/000490727. Epub 2018 Sep 18.
6
Unlocking the Potential of Artificial Intelligence in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Curr Hematol Malig Rep. 2024 Feb;19(1):9-17. doi: 10.1007/s11899-023-00716-5. Epub 2023 Nov 24.
7
Multicentric study underlining the interest of adding CD5, CD7 and CD56 expression assessment to the flow cytometric Ogata score in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
Haematologica. 2015 Apr;100(4):472-8. doi: 10.3324/haematol.2014.112755. Epub 2015 Jan 30.
8
Flow Cytometric Assessment of Myelodysplastic Syndromes/Neoplasms.
Clin Lab Med. 2023 Dec;43(4):521-547. doi: 10.1016/j.cll.2023.06.006. Epub 2023 Aug 7.
9
The current approach to the diagnosis of myelodysplastic syndromes.
Semin Hematol. 2019 Jan;56(1):15-21. doi: 10.1053/j.seminhematol.2018.05.015. Epub 2018 Jun 23.
10
Exploring blast composition in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms: CD45RA and CD371 improve diagnostic value of flow cytometry through assessment of myeloblast heterogeneity and stem cell aberrancy.
Cytometry B Clin Cytom. 2021 Sep;100(5):574-589. doi: 10.1002/cyto.b.21983. Epub 2020 Dec 24.
引用本文的文献
1
Integrating Molecular Alterations with Immunophenotype and Clinical Characteristics in Myelodysplastic Syndromes: A Single-Center Study.
Int J Mol Sci. 2025 Jul 30;26(15):7382. doi: 10.3390/ijms26157382.
本文引用的文献
1
Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.
NEJM Evid. 2022 Jul;1(7):EVIDoa2200008. doi: 10.1056/EVIDoa2200008. Epub 2022 Jun 12.
2
Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry.
Haematologica. 2023 Sep 1;108(9):2435-2443. doi: 10.3324/haematol.2022.282370.
3
Management of patients with lower-risk myelodysplastic syndromes.
Blood Cancer J. 2022 Dec 14;12(12):166. doi: 10.1038/s41408-022-00765-8.
4
Diabetic retinopathy screening in the emerging era of artificial intelligence.
Diabetologia. 2022 Sep;65(9):1415-1423. doi: 10.1007/s00125-022-05727-0. Epub 2022 May 31.
5
Machine Learning of Bone Marrow Histopathology Identifies Genetic and Clinical Determinants in Patients with MDS.
Blood Cancer Discov. 2021 Mar 22;2(3):238-249. doi: 10.1158/2643-3230.BCD-20-0162. eCollection 2021 May.
6
Computational flow cytometry as a diagnostic tool in suspected-myelodysplastic syndromes.
Cytometry A. 2021 Aug;99(8):814-824. doi: 10.1002/cyto.a.24360. Epub 2021 May 12.
7
Artificial intelligence for clinical oncology.
Cancer Cell. 2021 Jul 12;39(7):916-927. doi: 10.1016/j.ccell.2021.04.002. Epub 2021 Apr 29.
8
Computational analysis of flow cytometry data in hematological malignancies: future clinical practice?
Curr Opin Oncol. 2020 Mar;32(2):162-169. doi: 10.1097/CCO.0000000000000607.
9
A novel automated image analysis system using deep convolutional neural networks can assist to differentiate MDS and AA.
Sci Rep. 2019 Sep 16;9(1):13385. doi: 10.1038/s41598-019-49942-z.
10
The practical implementation of artificial intelligence technologies in medicine.
Nat Med. 2019 Jan;25(1):30-36. doi: 10.1038/s41591-018-0307-0. Epub 2019 Jan 7.
Zotero 插件